The article, “A randomized controlled trial of botulinum toxin A for treating
neuropathic pain in patients with spinal cord injury”,[ which appeared in Volume 96, Issue 20 of
Medicine, has been retracted for plagiarism and academic fraud. Similar
design study, language, and tables were found in a previously published article,
“Botulinum toxin type A for neuropathic pain in patients with spinal cord
injury”,[ which appeared in
Volume 79, Issue 4 of Annals of Neurology, without any attribution or
citation.